# Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

> **NCT00811408** · PHASE1 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 24 (estimated)

## Conditions studied

- Cervical Cancer
- Precancerous Condition

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cidofovir
- **GENETIC:** protein expression analysis
- **OTHER:** laboratory biomarker analysis
- **RADIATION:** brachytherapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00811408
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2009-10
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811408, "Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00811408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*